Breaking News Instant updates and real-time market news.

2022-05-23 08:31:34 CRM Salesforce $159.67 / +4.26 (+2.74%) 08:31 05/23/22 05/23 08:31 05/23/22 08:31	Salesforce price target lowered to $260 from $330 at Jefferies Jefferies analyst Brent Thill lowered the firm's price target on Salesforce to $260 from $330 and keeps a Buy rating on the shares. Thill has lowered forecasts across 28 software companies he covers given stiffening economic headwinds and the looming risk of recession and the multiples embedded in his new price targets are 25% lower, though he warns investors that he believes there could still be downside to multiples if fundamentals weaken further.	31 May 09 Jun

2022-05-23 08:31:34

CRM

Salesforce

$159.67 / +4.26 (+2.74%)

08:31

05/23/22

05/23

08:31

05/23/22

08:31

Salesforce price target lowered to $260 from $330 at Jefferies

Jefferies analyst Brent Thill lowered the firm's price target on Salesforce to $260 from $330 and keeps a Buy rating on the shares. Thill has lowered forecasts across 28 software companies he covers given stiffening economic headwinds and the looming risk of recession and the multiples embedded in his new price targets are 25% lower, though he warns investors that he believes there could still be downside to multiples if fundamentals weaken further.

31
May
09
Jun

OTHER BREAKING NEWS FROM THE FLY

Upgrade	First Commonwealth upgraded to Outperform from Market Perform at Raymond James » 07:36 07/07/22 07/07 07:36 07/07/22 07:36 FCF First Commonwealth $13.57 / -0.13 (-0.95%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings FCF First Commonwealth $13.57 / -0.13 (-0.95%) 05/13/22 BM Technologies names John Dolan as new board member 04/26/22 First Commonwealth increases quarterly dividend 4.3% to 12c per share FCF First Commonwealth $13.57 / -0.13 (-0.95%) 04/12/22 B. Riley First Commonwealth price target lowered to $18 from $19 at B. Riley 01/27/22 B. Riley First Commonwealth upgraded to Buy from Neutral at B. Riley 01/27/22 B. Riley First Commonwealth upgraded to Buy from Neutral at B. Riley 01/12/22 B. Riley First Commonwealth price target raised to $16 from $15 at B. Riley FCF First Commonwealth $13.57 / -0.13 (-0.95%) 04/26/22 First Commonwealth reports Q1 core EPS 29c, consensus 30c 01/25/22 First Commonwealth reports Q4 EPS 37c, consensus 33c
Hot Stocks	Intercept says OCA 25 meets primary endpoint in Phase 3 REGENERATE study » 07:35 07/07/22 07/07 07:35 07/07/22 07:35 ICPT Intercept $15.28 / +0.14 (+0.92%) Intercept Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ICPT Intercept $15.28 / +0.14 (+0.92%) 07:31 Today Intercept trading halted, news pending 06/06/22 Intercept announces FDA pre-submission meeting for NASH NDA moved to July 06/03/22 Intercept announces results from two studies evaluating Ocaliva 05/11/22 Intercept announces first patient dosed oin Phase 2 OCA, bezafibrate trial ICPT Intercept $15.28 / +0.14 (+0.92%) 05/10/22 B. Riley Intercept price target raised to $32 from $30 at B. Riley 05/09/22 Raymond James Intercept price target lowered to $23 from $44 at Raymond James 05/06/22 Piper Sandler Piper Sandler remains bullish on Intercept with $82 target 03/08/22 Canaccord Intercept price target lowered to $29 from $31 at Canaccord ICPT Intercept $15.28 / +0.14 (+0.92%) 05/06/22 Intercept reports Q1 EPS (58c), consensus (91c) 03/02/22 Intercept reports Q4 EPS ($1.23), consensus ($1.10) ICPT Intercept $15.28 / +0.14 (+0.92%) 05/05/22 What You Missed On Wall Street On Thursday 05/05/22 What You Missed On Wall Street This Morning
Options	Unusual call flow in option market yesterday » 07:35 07/07/22 07/07 07:35 07/07/22 07:35 SNAP Snap $14.28 / -0.11 (-0.76%) , CANO Cano Health $5.62 / +0.82 (+17.08%) Notable call activity was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SNAP CANO SNAP Snap $14.28 / -0.11 (-0.76%) 06/29/22 Snap announces Snapchat+ subscription service 06/21/22 Snap CEO sees 'ton of headroom' to grow considering size of audience 06/21/22 Snap CEO calls paid subscription test 'an exciting opportunity' 06/21/22 Snap CEO says not concerned by share price, focused on long-term CANO Cano Health $5.62 / +0.82 (+17.08%) 07/06/22 Cano Health rises 16.0% 07/06/22 Cano Health rises 15.0% 05/09/22 Cano Health sees 2H MCR significantly lower than 1H total MCR 04/20/22 Cano Health rises 10.5% SNAP CANO SNAP Snap $14.28 / -0.11 (-0.76%) 07/05/22 Barclays Snap price target lowered to $20 from $42 at Barclays 06/30/22 JMP Securities Snap price target lowered to $42 from $45 at JMP Securities 06/29/22 JPMorgan Snap price target lowered to $24 from $26 at JPMorgan 06/22/22 Guggenheim Snap price target lowered to $18 from $35 at Guggenheim CANO Cano Health $5.62 / +0.82 (+17.08%) 06/24/22 Raymond James Cano Health initiated with an Outperform at Raymond James 06/24/22 Raymond James Cano Health initiated with an Outperform at Raymond James 06/15/22 BofA Cano Health downgraded to Neutral on above-average leverage at BofA 06/15/22 BofA Cano Health downgraded to Neutral from Buy at BofA SNAP CANO SNAP Snap $14.28 / -0.11 (-0.76%) 05/23/22 Snap sees Q2 revenue, adjusted EBITDA below low end of prior guidance 04/21/22 Snap sees Q2 revenue up 20%-25% y/y, consensus $1.26B 04/21/22 Snap reports Q1 EPS (2c), consensus 1c 04/21/22 Notable companies reporting after market close CANO Cano Health $5.62 / +0.82 (+17.08%) 06/07/22 Cano Health maintains 2022 revenue view $2.8B-$2.9B, consensus $2.86B 05/09/22 Cano Health sees 2022 revenue $2.8B-$2.9B, consensus $2.83B 05/09/22 Cano Health reports Q1 revenue $704.3M, consensus $655.49M 03/14/22 Cano Health raises FY22 adjusted EBITDA view to $230M-$240M from $170M-$175M SNAP SNAP Snap $14.28 / -0.11 (-0.76%) 06/28/22 Meta, Snap could face penalties for addicting children in California, WSJ says 06/17/22 Snap tells The Verge testing paid subscription called Snapchat Plus 05/23/22 Snap to slow hiring through end of year, CNBC reports 04/26/22 Tech giants tricked into giving out personal user data, Bloomberg says SNAP CANO SNAP Snap $14.28 / -0.11 (-0.76%) 07/06/22 #SocialStocks: Twitter and Indian government battle over blocking orders 07/01/22 Sell these stocks now, proven algorithm says 06/29/22 #SocialStocks: Pinterest taps former Google executive as CEO 06/22/22 #SocialStocks: Twitter board unanimously backs deal with Elon Musk CANO Cano Health $5.62 / +0.82 (+17.08%) 06/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/20/22 What You Missed On Wall Street On Wednesday 07/20/22 Snap - SNAP 07/21/22 Snap - SNAP 07/20/22 Snap Inc. SNAP CANO SNAP Snap $14.28 / -0.11 (-0.76%) 07/06/22 Call buyer snaps up 7k 16-day Snapchat calls into earnings 06/03/22 Notable open interest changes for June 3rd 05/25/22 Unusually active option classes on open May 25th 05/25/22 Notable open interest changes for May 25th CANO Cano Health $5.62 / +0.82 (+17.08%) 07/06/22 Cano Health call volume spikes as shares jump 20% 03/10/22 Unusually active option classes on open March 10th
Hot Stocks	iSpecimen adds two biospecimen suppliers to proprietary Marketplace platform » 07:34 07/07/22 07/07 07:34 07/07/22 07:34 ISPC iSpecimen $2.41 / +0.16 (+7.11%) iSpecimen has added new… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ISPC iSpecimen $2.41 / +0.16 (+7.11%) 06/08/22 iSpecimen appoints Evan Cox as VP, product managment 05/19/22 iSpecimen presnets research on biobanking at ISBER Annual Meeting 04/26/22 iSpecimen unveils iSpecimen Marketplace platform 04/13/22 iSpecimen adds Acutis Diagnostics to marketplace platform ISPC iSpecimen $2.41 / +0.16 (+7.11%) 01/04/22 Craig-Hallum Craig-Hallum bullish on iSpecimen, initiates with a Buy 01/04/22 Craig-Hallum iSpecimen initiated with a Buy at Craig-Hallum ISPC iSpecimen $2.41 / +0.16 (+7.11%) 02/17/22 iSpecimen reports 2021 EPS ($2.09), two est. ($2.03)
Upgrade	Bunge upgraded to Overweight from Neutral at JPMorgan » 07:32 07/07/22 07/07 07:32 07/07/22 07:32 BG Bunge $85.83 / -0.78 (-0.90%) JPMorgan analyst Thomas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BG Bunge $85.83 / -0.78 (-0.90%) 05/12/22 Bunge boosts quarterly dividend 19% to 62.5c per share 04/20/22 Bunge announces external volume reporting changes 02/22/22 Bunge signs JV agreement with Chevron 01/20/22 Bunge to acquire 33% stake in Sinagro, terms undisclosed BG Bunge $85.83 / -0.78 (-0.90%) 06/30/22 BofA Bunge upgraded to Buy from Neutral at BofA 06/24/22 Credit Suisse Bunge price target lowered to $125 from $140 at Credit Suisse 04/28/22 Credit Suisse Bunge price target raised to $140 from $120 at Credit Suisse 04/19/22 BofA BofA cuts Bunge to Neutral, sees company nearing peak earnings BG Bunge $85.83 / -0.78 (-0.90%) 04/27/22 Bunge raises FY22 adjusted EPS view to at least $11.50 from at least $9.50 04/27/22 Bunge reports Q1 adjusted EPS $4.26, consensus $2.79 02/09/22 Bunge reports Q4 adjusted EPS $3.49, consensus $2.52 02/09/22 Bunge sees FY22 adjusted EPS 'at least' $9.50, consensus $8.58 BG Bunge $85.83 / -0.78 (-0.90%) 06/30/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BG Bunge $85.83 / -0.78 (-0.90%) 05/12/22 Bunge put volume heavy and directionally bearish 04/05/22 Unusually active option classes on open April 5th
Hot Stocks	Sellas Life Sciences adds dose cohort in Phase 1 trial of CDK9 inhibitor » 07:32 07/07/22 07/07 07:32 07/07/22 07:32 SLS Sellas Life Sciences $2.42 / +0.04 (+1.68%) Sellas Life Sciences has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly SLS Sellas Life Sciences $2.42 / +0.04 (+1.68%) 06/27/22 Sellas Life Sciences provides clinical update for GFH009 ongoing Phase 1 trial 06/08/22 Sellas shares data on 'increased survival' from study of galinpepimut-S/Opdivo 05/26/22 Sellas Life Sciences reports preliminary data from Phase 1/2 trial of GPS 04/26/22 Sellas Life Sciences launches expanded access program for Galinpepimut-S SLS Sellas Life Sciences $2.42 / +0.04 (+1.68%) 06/28/22 Cantor Fitzgerald Sellas Life Sciences price target lowered to $6 from $10 at Cantor Fitzgerald 04/07/22 Alliance Global Partners Sellas Life Sciences price target lowered to $14 from $16.50 at Alliance Global Partners 12/03/21 Cantor Fitzgerald Sellas Life Sciences price target lowered to $16 from $18 at Cantor Fitzgerald 07/21/21 Cantor Fitzgerald Sellas Life Sciences initiated with an Overweight at Cantor Fitzgerald 01 Apr SLS Sellas Life Sciences $2.42 / +0.04 (+1.68%) 04/01/22 Fly Intel: Pre-market Movers 03/31/22 Fly Intel: After-Hours Movers
Downgrade	Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James » 07:32 07/07/22 07/07 07:32 07/07/22 07:32 BSRR Sierra Bancorp $21.48 / -0.18 (-0.83%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings BSRR Sierra Bancorp $21.48 / -0.18 (-0.83%) 06:34 Today Raymond James Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James 01/25/22 Janney Montgomery Scott Sierra Bancorp downgraded to Neutral from Buy at Janney Montgomery Scott 12/21/21 Keefe Bruyette Keefe Bruyette assumes four California small- and mid-cap banks 12/20/21 Keefe Bruyette Sierra Bancorp assumed with an Outperform at Keefe Bruyette BSRR Sierra Bancorp $21.48 / -0.18 (-0.83%) 04/25/22 Sierra Bancorp reports Q1 EPS 49c, consensus 60c 01/24/22 Sierra Bancorp reports Q4 EPS 63c, consensus 66c
Hot Stocks	Iris Energy reports 148 bitcoin mined in June » 07:32 07/07/22 07/07 07:32 07/07/22 07:32 IREN Iris Energy $3.29 / -0.105 (-3.09%) Iris Energy published a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options IREN Iris Energy $3.29 / -0.105 (-3.09%) 06/21/22 Iris Energy provides updated operating & CapEx guidance 06/07/22 Iris Energy reports 151 bitcoin mined in May 05/16/22 Iris Energy appoints Belinda Nucifora as CFO 05/05/22 Iris Energy reports 137 bitcoin mined in April IREN Iris Energy $3.29 / -0.105 (-3.09%) 06/28/22 Compass Point Iris Energy price target lowered to $5 from $20 at Compass Point 06/28/22 Cantor Fitzgerald Iris Energy assumed with an Overweight at Cantor Fitzgerald 05/12/22 Canaccord Iris Energy price target lowered to $14 from $25 at Canaccord 03/09/22 Cantor Fitzgerald Iris Energy price target lowered to $22 from $25 at Cantor Fitzgerald IREN Iris Energy $3.29 / -0.105 (-3.09%) 05/11/22 Iris Energy reports Q3 revenue $15.2M, consensus $19.93M 03/08/22 Iris Energy reports Q4 revenue $20M, consensus $19.9M 02/09/22 Iris Energy reports Q2 revenue $20.02M, consensus $20.81M 17 Nov IREN Iris Energy $3.29 / -0.105 (-3.09%) 03/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations IREN Iris Energy $3.29 / -0.105 (-3.09%) 04/29/22 Fourteen new option listings and one option delisting on April 29th
Hot Stocks	Meridian Bioscience trading halted, news pending 07:31 07/07/22 07/07 07:31 07/07/22 07:31 VIVO Meridian Bioscience $33.60 / +2.33 (+7.45%) ShowHide Related Items >><< Company News Street Research Earnings VIVO Meridian Bioscience $33.60 / +2.33 (+7.45%) 07:25 Today Meridian to be acquired by SD Biosensor, SJL Partners for $34 per share in cash 07:23 Today Meridian to be acquired by SD Biosensor, SJL Partners for $34 per share 05/02/22 Meridian Bioscience subsidiary acquires Euprotein 03/29/22 Meridian Bioscience announces launch of two new master mixes VIVO Meridian Bioscience $33.60 / +2.33 (+7.45%) 02/07/22 H.C. Wainwright Meridian Bioscience price target raised to $30 from $28 at H.C. Wainwright VIVO Meridian Bioscience $33.60 / +2.33 (+7.45%) 07:20 Today Meridian Bioscience sees Q3 revenue $66M-$69M 04/07/22 Meridian Bioscience sees Q2 revenue $109M-$113M, consensus $83.29M 02/04/22 Meridian Bioscience raises FY22 adjusted EPS view to $1.10-$1.30 from 98c-$1.07 02/04/22 Meridian Bioscience reports Q1 EPS 35c, consensus 25c
Hot Stocks	Intercept trading halted, news pending 07:31 07/07/22 07/07 07:31 07/07/22 07:31 ICPT Intercept $15.28 / +0.14 (+0.92%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly ICPT Intercept $15.28 / +0.14 (+0.92%) 06/06/22 Intercept announces FDA pre-submission meeting for NASH NDA moved to July 06/03/22 Intercept announces results from two studies evaluating Ocaliva 05/11/22 Intercept announces first patient dosed oin Phase 2 OCA, bezafibrate trial 05/05/22 Intercept reports Advanz to acquire Ocaliva rights outside U.S. for up to $450M ICPT Intercept $15.28 / +0.14 (+0.92%) 05/10/22 B. Riley Intercept price target raised to $32 from $30 at B. Riley 05/09/22 Raymond James Intercept price target lowered to $23 from $44 at Raymond James 05/06/22 Piper Sandler Piper Sandler remains bullish on Intercept with $82 target 03/08/22 Canaccord Intercept price target lowered to $29 from $31 at Canaccord ICPT Intercept $15.28 / +0.14 (+0.92%) 05/06/22 Intercept reports Q1 EPS (58c), consensus (91c) 03/02/22 Intercept reports Q4 EPS ($1.23), consensus ($1.10) ICPT Intercept $15.28 / +0.14 (+0.92%) 05/05/22 What You Missed On Wall Street On Thursday 05/05/22 What You Missed On Wall Street This Morning

Downgrade	Veritex downgraded to Outperform from Strong Buy at Raymond James » 07:31 07/07/22 07/07 07:31 07/07/22 07:31 VBTX Veritex $29.81 / +0.01 (+0.03%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate VBTX Veritex $29.81 / +0.01 (+0.03%) 03/09/22 Veritex director Arcilia Acosta acquires 26,316 common shares 03/09/22 Veritex director Pat Bolin acquires 13,158 common shares 03/03/22 Veritex commences common stock offering 03/03/22 Veritex to acquire interLink in $91M cash and stock transaction VBTX Veritex $29.81 / +0.01 (+0.03%) 06:26 Today Raymond James Veritex downgraded to Outperform from Strong Buy at Raymond James 06/13/22 DA Davidson DA Davidson says recent and pending investments by Veritex support tailwinds 01/27/22 Raymond James Veritex price target raised to $49 from $46 at Raymond James 10/28/21 Piper Sandler Veritex price target raised to $46 from $42 at Piper Sandler 04 Mar
Downgrade	Preferred Bank downgraded to Market Perform from Outperform at Raymond James » 07:31 07/07/22 07/07 07:31 07/07/22 07:31 PFBC Preferred Bank $69.23 / +0.55 (+0.80%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PFBC Preferred Bank $69.23 / +0.55 (+0.80%) 06/07/22 Preferred Bank re-commences buyback plan for up to approximately $32M in stock PFBC Preferred Bank $69.23 / +0.55 (+0.80%) 04/12/22 B. Riley Preferred Bank price target lowered to $95 from $100 at B. Riley 02/16/22 Janney Montgomery Scott Preferred Bank upgraded to Buy from Neutral at Janney Montgomery Scott 01/24/22 Piper Sandler Preferred Bank price target raised to $94 from $85 at Piper Sandler 01/21/22 B. Riley Preferred Bank price target raised to $100 from $95 at B. Riley PFBC Preferred Bank $69.23 / +0.55 (+0.80%) 04/19/22 Preferred Bank reports Q1 EPS $1.74, consensus $1.69 01/19/22 Preferred Bank reports Q4 EPS $1.80, consensus $1.72
Downgrade	United Airlines downgraded to Hold from Buy at Argus » 07:30 07/07/22 07/07 07:30 07/07/22 07:30 UAL United Airlines $36.67 / -0.31 (-0.84%) Argus analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options UAL United Airlines $36.67 / -0.31 (-0.84%) 07/05/22 U.S. DOT reassigns 16 'peak-hour' runway timings to Spirit Airlines 06/16/22 T-Mobile to offer free in-flight connectivity on select flights starting June 21 06/15/22 United Airlines debuts plant-based menu items from Impossible Foods 06/08/22 United Airlines announces nonstop service between San Francisco and Brisbane UAL United Airlines $36.67 / -0.31 (-0.84%) 06/27/22 Evercore ISI United Airlines price target lowered to $45 from $56 at Evercore ISI 06/23/22 Citi Citi adds AutoZone, Thermo Fisher, Ionis to 'Focus List' 06/23/22 Raymond James United Airlines price target lowered to $48 from $62 at Raymond James 06/22/22 Citi Citi says this is not 2020 or 2008 for airline stocks UAL United Airlines $36.67 / -0.31 (-0.84%) 04/20/22 United Airlines reports Q1 adjusted EPS ($4.24), consensus ($4.21) 04/20/22 Notable companies reporting after market close 03/15/22 United Airlines sees Q1 capacity down approximately 19% 01/19/22 United Airlines sees FY22 capacity down vs 2019 UAL United Airlines $36.67 / -0.31 (-0.84%) 07/06/22 United Airlines blames FAA for worsening industry's issues, Bloomberg reports 06/30/22 American Airlines offers pilots almost 17% in pay hikes, CNBC says 06/27/22 Airlines cancel over 700 flights in U.S. on Monday, Reuters reports 06/24/22 United Airlines pilots agree to 14.5% pay raise, CNBC reports UAL United Airlines $36.67 / -0.31 (-0.84%) 07/06/22 What You Missed On Wall Street This Morning 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 06/13/22 Fly Insider: Tela Bio, Airbnb among week's notable insider trades 07/21/22 United Airlines - UAL UAL United Airlines $36.67 / -0.31 (-0.84%) 07/05/22 Unusually active option classes on open July 5th 07/01/22 United Continental call volume above normal and directionally bullish 06/28/22 Early notable gainers among liquid option names on June 28th 05/20/22 United Continental call volume above normal and directionally bullish
Initiation	Emerson Electric resumed with a Neutral at JPMorgan » 07:29 07/07/22 07/07 07:29 07/07/22 07:29 EMR Emerson Electric / + JPMorgan analyst Stephen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly EMR Emerson Electric / + 06/30/22 Emerson acquires life sciences company Fluxa, no terms 05/04/22 Emerson Electric exits Russia business 03/03/22 One Rock Capital to acquire Therm-O-Disc from Emerson, terms not disclosed 02/02/22 Emerson Electric sees FY22 operating cash flow $3.8B, free cash flow $3.1B EMR Emerson Electric / + 06/06/22 BofA Aspen Technology price target raised to $230 from $176 at BofA 05/24/22 Barclays Emerson Electric price target lowered to $87 from $92 at Barclays 05/17/22 Citi Emerson Electric price target lowered to $111 from $119 at Citi 05/09/22 Oppenheimer Emerson Electric price target lowered to $110 from $115 at Oppenheimer EMR Emerson Electric / + 05/04/22 Emerson Electric sees Q3 adjusted EPS $1.25-$1.30, consensus $1.33 05/04/22 Emerson Electric raises FY22 adjusted EPS view to $4.95-$5.10 from $4.90-$5.05 05/04/22 Emerson Electric reports Q2 adjusted EPS $1.29, consensus $1.18 02/02/22 Emerson Electric sees Q2 adjusted EPS $1.15-$1.20, consensus $1.19 EMR Emerson Electric / + 05/25/22 Emerson Electric weighs $3B sale of garbage disposal arm, Bloomberg reports EMR Emerson Electric / + 03/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/02/22 Wall Street in Fives - Must Read Lists for Wednesday 02/02/22 Wall Street in Fives - Must Read Lists at Midday 02/02/22 Fly Intel: Pre-market Movers
Downgrade	FS Bancorp cut to Market Perform at Raymond James amid aggressive Fed tightening » 07:29 07/07/22 07/07 07:29 07/07/22 07:29 FSBW FS Bancorp $28.95 / -0.09 (-0.31%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings FSBW FS Bancorp $28.95 / -0.09 (-0.31%) 04/06/22 FS Bancorp announces 10c per share special dividend, additional $10M to buyback 01/27/22 FS Bancorp raises quarterly dividend to 20c from 15c per share FSBW FS Bancorp $28.95 / -0.09 (-0.31%) 06:29 Today Raymond James FS Bancorp downgraded to Market Perform from Outperform at Raymond James FSBW FS Bancorp $28.95 / -0.09 (-0.31%) 04/28/22 FS Bancorp reports Q1 EPS 81c, consensus 71c 01/27/22 FS Bancorp reports Q4 EPS $1.01, consensus 85c
Downgrade	Otis Worldwide downgraded on 'premium' valuation at JPMorgan » 07:28 07/07/22 07/07 07:28 07/07/22 07:28 OTIS Otis Worldwide $71.23 / -0.185 (-0.26%) JPMorgan analyst Stephen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly OTIS Otis Worldwide $71.23 / -0.185 (-0.26%) 06/27/22 General Electric announces changes to GE Aviation senior leadership team 06/27/22 Otis Worldwide appoints Anurag Maheshwari EVP, CFO 04/22/22 Otis Worldwide raises quarterly dividend 20.8% to 29c per share 04/08/22 Otis Worldwide receives results of Zardoya tender offer OTIS Otis Worldwide $71.23 / -0.185 (-0.26%) 06:40 Today JPMorgan Otis Worldwide downgraded to Neutral from Overweight at JPMorgan 07/04/22 Exane BNP Paribas Otis Worldwide downgraded to Neutral from Outperform at Exane BNP Paribas 06/22/22 Berenberg Otis Worldwide price target lowered to $80 from $88 at Berenberg 05/24/22 Barclays Otis Worldwide upgraded to Overweight from Equal Weight at Barclays OTIS Otis Worldwide $71.23 / -0.185 (-0.26%) 04/25/22 Otis Worldwide raises FY22 adjusted EPS view to $3.22-$3.27 from up 6%-10% 04/25/22 Otis Worldwide reports Q1 adjusted EPS 77c, consensus 74c 02/15/22 Otis Worldwide backs FY22 EPS view up 6%-10%, consensus $3.28 01/31/22 Otis Worldwide sees FY22 adjusted EPS $3.20-$3.30, consensus $3.29 OTIS Otis Worldwide $71.23 / -0.185 (-0.26%) 03/22/22 Toshiba's elevator unit draws interest from Midea, Otis, Bloomberg says 03/22/22 Toshiba's elevator unit draws interest from Midea, Otis, Bloomberg says OTIS Otis Worldwide $71.23 / -0.185 (-0.26%) 05/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/25/22 What You Missed On Wall Street On Monday 04/25/22 What You Missed On Wall Street This Morning 03/22/22 What You Missed On Wall Street On Tuesday
Downgrade	PNC Financial downgraded to Market Perform from Outperform at Raymond James » 07:28 07/07/22 07/07 07:28 07/07/22 07:28 PNC PNC Financial $160.03 / -1.05 (-0.65%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PNC PNC Financial $160.03 / -1.05 (-0.65%) 06/27/22 PNC Financial announces CCAR results 06/23/22 PNC Financial releases results of Dodd-Frank stress tests 06/21/22 Exela Technologies closes $150M securitization facility with PNC Bank 06/15/22 PNC Financial increases prime lending rate to 4.75% PNC PNC Financial $160.03 / -1.05 (-0.65%) 06:26 Today Raymond James PNC Financial downgraded to Market Perform from Outperform at Raymond James 07/01/22 Oppenheimer Oppenheimer says U.S. financial institutions 'dramatically undervalued' 05/26/22 Wolfe Research PNC Financial price target lowered to $177 from $223 at Wolfe Research 04/18/22 Argus PNC Financial price target lowered to $220 from $245 at Argus PNC PNC Financial $160.03 / -1.05 (-0.65%) 04/14/22 PNC Financial reports Q1 adjusted EPS $3.29, consensus $2.73 04/13/22 Notable companies reporting before tomorrow's open 04/13/22 Notable companies reporting before tomorrow's open 01/18/22 PNC Financial sees Q1 revenue down 3%-5%, consensus $5B PNC PNC Financial $160.03 / -1.05 (-0.65%) 04/14/22 Fly Intel: Pre-market Movers 04/13/22 Here's what Wall St. experts are saying about these banks ahead of earnings 01/18/22 Fly Intel: Wall Street's top stories for Tuesday 01/18/22 Wall Street in Fives - Must Read Lists at Midday 07/15/22 PNC Financial - PNC PNC PNC Financial $160.03 / -1.05 (-0.65%) 01/21/22 PNC Financial put volume heavy and directionally bearish
Conference/Events	Deere management to meet with Oppenheimer » 07:27 07/07/22 07/07 07:27 07/07/22 07:27 DE Deere $289.17 / -3.13 (-1.07%) Meetings to be held on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DE Deere $289.17 / -3.13 (-1.07%) 05/31/22 Deere names Raj Kalathur as CFO 05/31/22 Allegion CEO David Petratis to retire, John Stone to succeed 05/25/22 Deere boosts quarterly dividend by 8% to $1.13 per share 05/20/22 Deere falls -11.8% DE Deere $289.17 / -3.13 (-1.07%) 06/09/22 Cowen Deere initiated with a Market Perform at Cowen 05/23/22 Stifel Stifel trims Deere target to $425, calls post-earnings pullback 'overblown' 05/23/22 Oppenheimer Deere price target lowered to $419 from $446 at Oppenheimer 05/23/22 DA Davidson Deere price target lowered to $445 from $480 at DA Davidson DE Deere $289.17 / -3.13 (-1.07%) 05/20/22 Deere reports Q2 EPS $6.81, consensus $6.71 05/19/22 Notable companies reporting before tomorrow's open 05/19/22 Notable companies reporting before tomorrow's open 02/18/22 Deere reports Q1 EPS $2.92, consensus $2.26 DE Deere $289.17 / -3.13 (-1.07%) 05/31/22 Farmer says dealer wouldn't repair without FTC complaint, Vice reports 03/22/22 Agriculture stocks see increased demand amid Ukraine turmoil, Bloomberg says 03/19/22 Brinker, Starbucks among stocks to buy among rising food costs, Barron's says 02/26/22 Deere among quality companies doing business mostly in the U.S., Barron's says DE Deere $289.17 / -3.13 (-1.07%) 06/09/22 What You Missed On Wall Street On Thursday 06/09/22 What You Missed On Wall Street This Morning 06/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/20/22 What You Missed On Wall Street On Friday 07/14/22 Deere 07/15/22 Deere DE Deere $289.17 / -3.13 (-1.07%) 06/30/22 Deere call volume above normal and directionally bullish 05/23/22 Early notable gainers among liquid option names on May 23rd 05/20/22 Unusually active option classes on open May 20th 03/11/22 Early notable gainers among liquid option names on March 11th
Upgrade	Allegiance Bancshares upgraded to Outperform from Market Perform at Raymond James » 07:27 07/07/22 07/07 07:27 07/07/22 07:27 ABTX Allegiance Bancshares $38.93 / -0.28 (-0.71%) , CBTX CBTX $27.36 / -0.03 (-0.11%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ABTX CBTX ABTX Allegiance Bancshares $38.93 / -0.28 (-0.71%) 06/16/22 CBTX, Allegiance Bancshares announce FDIC approval of merger of equals 05/24/22 CBTX, Allegiance Bancshares shareholders approve merger 05/17/22 CBTX, Allegiance Bancshares introduce Stellar Bank resulting from merger 04/29/22 Allegiance Bancshares expects to close CBTX merger in Q2 CBTX CBTX $27.36 / -0.03 (-0.11%) 06/16/22 CBTX, Allegiance Bancshares announce FDIC approval of merger of equals 05/24/22 CBTX, Allegiance Bancshares shareholders approve merger 05/17/22 CBTX, Allegiance Bancshares introduce Stellar Bank resulting from merger 04/29/22 Allegiance Bancshares expects to close CBTX merger in Q2 ABTX CBTX ABTX Allegiance Bancshares $38.93 / -0.28 (-0.71%) 06:34 Today Raymond James Allegiance Bancshares upgraded to Outperform from Market Perform at Raymond James CBTX CBTX $27.36 / -0.03 (-0.11%) ABTX CBTX ABTX Allegiance Bancshares $38.93 / -0.28 (-0.71%) 04/29/22 Allegiance Bancshares reports Q1 EPS 91c, consensus 82c 01/28/22 Allegiance Bancshares reports Q4 EPS $1.06, consensus 95c CBTX CBTX $27.36 / -0.03 (-0.11%) 04/28/22 CBTX reports Q1 EPS , consensus 43c, consensus 32c 01/27/22 CBTX reports Q4 EPS (2c), consensus 33c
Conference/Events	Calavo Growers management to meet virtually with Lake Street » 07:26 07/07/22 07/07 07:26 07/07/22 07:26 CVGW Calavo Growers $42.59 / -0.09 (-0.21%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CVGW Calavo Growers $42.59 / -0.09 (-0.21%) 06/21/22 Calavo Growers names Danny Dumas to lead Grown segment 06/09/22 Calavo Growers names Shawn Munsell as CFO 05/04/22 Tupperware Brands names Mariela Matute as new CFO 05/03/22 Calavo Growers announces departure of CFO Mariela Matute CVGW Calavo Growers $42.59 / -0.09 (-0.21%) 06/03/22 Lake Street Calavo Q2 offered 'most significant signs of a turnaround yet,' says Lake Street 12/21/21 Lake Street Calavo Growers results 'should provide comfort,' says Lake Street 09/09/21 Lake Street Calavo Growers price target lowered to $60 from $70 at Lake Street 08/05/21 Lake Street Calavo Growers price target lowered to $70 from $85 at Lake Street CVGW Calavo Growers $42.59 / -0.09 (-0.21%) 06/02/22 Calavo Growers reports Q2 EPS 33c, consensus 22c 03/14/22 Calavo Growers reports Q1 adjusted EPS (2c), consensus 5c 07/14/22 Calavo Growers - CVGW 07/14/22 Calavo Growers

Upgrade	Texas Capital upgraded to Strong Buy from Outperform at Raymond James » 07:26 07/07/22 07/07 07:26 07/07/22 07:26 TCBI Texas Capital $53.10 / -0.25 (-0.47%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TCBI Texas Capital $53.10 / -0.25 (-0.47%) 04/20/22 Regulatory ratios in excess of 'well-capitalized' requirements as of March 31 02/22/22 Texas Capital partners with Huston-Tillotson University 02/09/22 Bask Bank expands product set with high-yield interest savings account 01/20/22 Texas Capital names John Cummings EVP, Chief Administrative Officer TCBI Texas Capital $53.10 / -0.25 (-0.47%) 06:25 Today Raymond James Texas Capital upgraded to Strong Buy from Outperform at Raymond James 06/15/22 Truist Texas Capital price target lowered to $65 from $69 at Truist 01/18/22 BofA Texas Capital reinstated with a Neutral at BofA 09/02/21 Wedbush Texas Capital downgraded to Neutral at Wedbush TCBI Texas Capital $53.10 / -0.25 (-0.47%) 04/20/22 Texas Capital reports Q1 EPS 69c, consensus 73c TCBI Texas Capital $53.10 / -0.25 (-0.47%) 05/09/22 Fly Insider: Kennametal, Apple among notable insider trades this week 08/23/22 Texas Bank Summit TCBI Texas Capital $53.10 / -0.25 (-0.47%) 01/20/22 Texas Capital options imply 4.7% move in share price post-earnings
Conference/Events	Consensus Cloud Solutions management to meet virtually with Oppenheimer » 07:26 07/07/22 07/07 07:26 07/07/22 07:26 CCSI Consensus Cloud Solutions $47.17 / +1.17 (+2.54%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly Events CCSI Consensus Cloud Solutions $47.17 / +1.17 (+2.54%) 03/03/22 Wedbush Consensus Cloud Solutions price target lowered to $67 from $75 at Wedbush 03/03/22 JMP Securities Consensus Cloud Solutions initiated with an Outperform at JMP Securities 11/30/21 Wedbush Wedbush bullish on Consensus Cloud Solutions, initiates with an Outperform 11/30/21 Wedbush Consensus Cloud Solutions initiated with an Outperform at Wedbush CCSI Consensus Cloud Solutions $47.17 / +1.17 (+2.54%) 05/16/22 Consensus Cloud Solutions backs FY22 EPS view $5.36-$5.50, consensus $5.40 05/16/22 Consensus Cloud Solutions reports Q1 adjusted EPS $1.33, consensus $1.26 03/02/22 Consensus Cloud Solutions sees FY22 adjusted EPS $5.47-$5.61, consensus $5.49 03/02/22 Consensus Cloud Solutions reports preliminary Q4 adjusted EPS $1.36 10 Jun CCSI Consensus Cloud Solutions $47.17 / +1.17 (+2.54%) 03/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/09/22 Consensus Cloud Solutions - CCSI 07/14/22 Consensus Cloud Solutions
Hot Stocks	Meridian to be acquired by SD Biosensor, SJL Partners for $34 per share in cash » 07:25 07/07/22 07/07 07:25 07/07/22 07:25 VIVO Meridian Bioscience $33.60 / +2.33 (+7.45%) Meridian Bioscience and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VIVO Meridian Bioscience $33.60 / +2.33 (+7.45%) 07:23 Today Meridian to be acquired by SD Biosensor, SJL Partners for $34 per share 05/02/22 Meridian Bioscience subsidiary acquires Euprotein 03/29/22 Meridian Bioscience announces launch of two new master mixes 01/31/22 Meridian receives NIH award to support Revogene panel development VIVO Meridian Bioscience $33.60 / +2.33 (+7.45%) 02/07/22 H.C. Wainwright Meridian Bioscience price target raised to $30 from $28 at H.C. Wainwright VIVO Meridian Bioscience $33.60 / +2.33 (+7.45%) 07:20 Today Meridian Bioscience sees Q3 revenue $66M-$69M 04/07/22 Meridian Bioscience sees Q2 revenue $109M-$113M, consensus $83.29M 02/04/22 Meridian Bioscience raises FY22 adjusted EPS view to $1.10-$1.30 from 98c-$1.07 02/04/22 Meridian Bioscience reports Q1 EPS 35c, consensus 25c
Upgrade	Heritage Commerce upgraded to Strong Buy from Outperform at Raymond James » 07:25 07/07/22 07/07 07:25 07/07/22 07:25 HTBK Heritage Commerce $10.84 / +0.005 (+0.05%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HTBK Heritage Commerce $10.84 / +0.005 (+0.05%) 05/02/22 Recruiter.com closes agreement with Bay View Funding 04/13/22 Heritage Commerce announces EVP Benito retires, Warford to succeed HTBK Heritage Commerce $10.84 / +0.005 (+0.05%) 12/28/21 Stephens Heritage Commerce initiated with an Overweight at Stephens 12/15/21 DA Davidson Heritage Commerce upgraded to Buy from Neutral at DA Davidson 12/14/21 DA Davidson Heritage Commerce upgraded to Buy from Neutral at DA Davidson HTBK Heritage Commerce $10.84 / +0.005 (+0.05%) 04/28/22 Heritage Commerce reports Q1 EPS 21c, consensus 20c 01/27/22 Heritage Commerce reports Q4 EPS 23c, consensus 22c
Downgrade	T2 Biosystems downgraded on 'broad-based' shortfall at BTIG » 07:24 07/07/22 07/07 07:24 07/07/22 07:24 TTOO T2 Biosystems / + BTIG analyst Mark Massaro… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TTOO T2 Biosystems / + 07/06/22 T2 Biosystems implements expense reductions including workforce reduction 06/10/22 T2 Biosystems granted extension from Nasdaq to comply with bid price rule 05/20/22 T2 Biosystems announces issuance of patent for direct detection of Lyme Disease 05/05/22 T2 Biosystems receives Nasdaq delisting notice TTOO T2 Biosystems / + 06:43 Today BTIG T2 Biosystems downgraded to Neutral from Buy at BTIG 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners 02/18/22 Canaccord T2 Biosystems price target lowered to $1.50 from $3.00 at Canaccord 01/18/22 Canaccord T2 Biosystems significantly undervalued at current levels, say Canaccord TTOO T2 Biosystems / + 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M 05/05/22 T2 Biosystems reports Q1 EPS (10c), consensus (7c) TTOO T2 Biosystems / + 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning

Events

Earnings calls, analyst events, roadshows and more

Today at 08:15

ADP Employment Report: Private Payrolls M/M: June 2022 Government Event
Today at 08:30

Initial Jobless Claims Level: Week 7/2/2022 Government Event
Today at 08:30

Jobless Claims: 4-Week Moving Average: Week 7/2/2022 Government Event
Today at 08:30

International Trade in Goods and Services Balance: May 2022 Government Event
Today at 08:30

Initial Jobless Claims Change: Week 7/2/2022 Government Event
NTIC
Today at 09:00

Northern Technologies - NTIC Conference Calls
BYRN
Today at 09:00

Byrna Technologies - BYRN Conference Calls
HELE
Today at 09:00

Helen of Troy - HELE Conference Calls
SAR
Today at 10:00

Saratoga Investment - SAR Conference Calls
BFI
Today at 10:00

BurgerFi International Inc Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	NAPA X NAPA Duckhorn Portfolio Spot Secondary Managers: Credit Suisse $20.73 5M Shares
Thurs	NCPL X NCPL Netcapital Secondary Managers: ThinkEquity $7.65 784K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Salesforce price target lowered to $260 from $330 at Jefferies

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access